dc.contributor
Institut Català de la Salut
dc.contributor
[Puledda F] Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK. [Sacco S] Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy. [Diener HC] Department of Neuroepidemiology, Institute for Medical Informatics, Biometry and Epidemiology, Faculty of Medicine, University DuisburgEssen, Essen, Germany. [Ashina M] Department of Neurology, Danish Headache Center, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. [Al-Khazali HM] Department of Neurology, Danish Headache Center, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark. [Ashina S] Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Department of Neurology and Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, USA. [Pozo-Rosich P] Unitat de Cefalees, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Puledda, Francesca
dc.contributor.author
Sacco, Simona
dc.contributor.author
Al-Khazali, Haidar Muhsen
dc.contributor.author
Ashina, Sait
dc.contributor.author
Diener, Hans-Christoph
dc.contributor.author
Ashina, Messoud
dc.contributor.author
Pozo-Rosich, Patricia
dc.date.accessioned
2024-11-01T02:59:55Z
dc.date.available
2024-11-01T02:59:55Z
dc.date.issued
2024-10-11T08:40:31Z
dc.date.issued
2024-10-11T08:40:31Z
dc.identifier
Puledda F, Sacco S, Diener HC, Ashina M, Al-Khazali HM, Ashina S, et al. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Cephalalgia. 2024 Aug;44(8):1–45.
dc.identifier
https://hdl.handle.net/11351/12049
dc.identifier
10.1177/03331024241252666
dc.identifier.uri
http://hdl.handle.net/11351/12049
dc.description.abstract
Practice recommendations; Acute treatment; Clinical questions
dc.description.abstract
Recomendaciones prácticas; Tratamiento agudo; Preguntas clínicas
dc.description.abstract
Recomanacions pràctiques; Tractament agut; Preguntes clíniques
dc.description.abstract
Background
In an effort to improve migraine management around the world, the International Headache Society (IHS) has here developed a list of practical recommendations for the acute pharmacological treatment of migraine. The recommendations are categorized into optimal and essential, in order to provide treatment options for all possible settings, including those with limited access to migraine medications.
Methods
An IHS steering committee developed a list of clinical questions based on practical issues in the management of migraine. A selected group of international senior and junior headache experts developed the recommendations, following expert consensus and the review of available national and international headache guidelines and guidance documents. Following the initial search, a bibliography of twenty-one national and international guidelines was created and reviewed by the working group.
Results
A total of seventeen questions addressing different aspects of acute migraine treatment have been outlined. For each of them we provide an optimal recommendation, to be used whenever possible, and an essential recommendation to be used when the optimal level cannot be attained.
Conclusion
Adoption of these international recommendations will improve the quality of acute migraine treatment around the world, even where pharmacological options remain limited.
dc.format
application/pdf
dc.publisher
SAGE Publications
dc.relation
Cephalalgia;44(8)
dc.relation
https://doi.org/10.1177/03331024241252666
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Migranya - Tractament
dc.subject
Analgèsics - Ús terapèutic
dc.subject
DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Headache Disorders::Headache Disorders, Primary::Migraine Disorders
dc.subject
Other subheadings::Other subheadings::Other subheadings::/drug therapy
dc.subject
CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Peripheral Nervous System Agents::Sensory System Agents::Analgesics
dc.subject
Other subheadings::Other subheadings::/therapeutic use
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos con cefaleas::cefaleas primarias::trastornos migrañosos
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::fármacos del sistema nervioso periférico::fármacos del sistema sensitivo::analgésicos
dc.subject
Otros calificadores::Otros calificadores::/uso terapéutico
dc.title
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
